31% more bullish than other Healthcare sector stocks. 1. *Close price adjusted for splits. , page-3. Last updated 15. ASX - Day Trading. Share. . Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. . Created with Sketch. Of course, IXC’s BoD need to win back credibility for the market to more fairly value IXC’s TBI ODD… Having gone through the roller-coaster over the past one week, with my emotions now settled – I will be (slowly) buying-up in. 59pm 09/11/2023 ? HotCopper has news, discussion, prices and market data on INCITEC PIVOT LIMITED. Latest Posts ForumsHalf Yearly Report and AccountsLooks like people are starting to wake up here and realise how bloody cheap IXC is. , page-6. IXC Price at posting: 44. Invex Therapeutics' Chief Scientific Officer, Professor Alexandra Sinclair, met with NASA's medical team. Forums. 147,415. ASX - By Stock. Market . . Market Cap $16. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. , page-136. 6B TAM that is unencumbered and a 55% peer average neurology success rate from Phase 3!IXC although only the 1 indication has already raised the sufficient cash to go all the way, they are in phase 3 trials, they have a time line and are full steam ahead. Although, IXC is trading about 3-4x lower than what I expect it to be. 38 Biotechnology stocks are valued based on a risk. Forums. Investor PresentationI would be worried about holding IXC if they had no more cash. Both approaches can work, but it is not wise to confuse the two. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. Appendix 4C - quarterly* or having a go at doing so, page-30. . 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. We are a team of expert financial advisers each specialising in different, yet complementary areas. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumFound this article a while back although raises some decent points. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportA new thread to put trading comments / reasoning / opinions in. Trading HaltIXC Valuation Report MST. is there any news release, or SP increasing due to only the market showing interestInvex Receives UK Approval to Commence Phase III TrialInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. , page-196. IXC Price at posting: 37. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. 9MB OEC: 22/11/2023 1:05 PM : Cleansing Notice 2 pages 172. ASX - By Stock. Postcard to ShareholdersIXC (ASX) Ann: Trading Halt - HotCopper. Forums. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. These are 2007 numbers. ASX - By Stock. 3¢. com. IXC Valuation Report MST. , page-3. Market . Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. I think having this out we can discuss on the way. , page-35. 147,415. 5¢ Sentiment: Buy Disclosure: Held. Proposed listing date: 4 JULY 2019#Created with Sketch. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. gov and there is lots of good information about the trial. , page-2. Market . . ASX - Day TradingA new thread to put trading comments / reasoning / opinions in. . Expand. Latest Posts ForumsiShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - Short Term Trading. Forgot Client ID or Password? If you're a CommBank customer, you can access CommSec from Netbank. Market . All IMO IXC Price at posting: 37. Created with Sketch. When can we expect some update or. ASX - By Stock. It certainly has been a hard few months for the biotech sector with PEB, NYR, NOX and now IXC all having prangs. . , page-2. 0. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak:Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. 333334. Created with Sketch. 0. 30 order I had out there for 2-3 weeks. I knew zero about the fundamentals of IXC. 8,369 likes · 140 talking about this · 1,407 were here. 76 (-1. Investor PresentationInvex Successfully Concludes Protocol Assistance with EMACreated with Sketch. Latest Posts. IXC Price at posting: 79. Charts. . 1950. Both approaches can work, but it is not wise to confuse the two. , page-188. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. 59). Transparency is our policy. See page-34. ASX - By Stock. sentiment based on opinions from HotCopper and others. Join the HotCopper ASX share market forum today for free. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited) At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. IXC – iShares Global Energy ETF – Check IXC price, review total assets, see historical growth, and review the. Created with Sketch. ASX - Day TradingI bought some today at 44. Market . pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 64440. . Join the HotCopper ASX share market forum today for free. IXC (ASX) Ann: Trading Halt - HotCopper. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. Target our investor community with our suite of Hotcopper Advertising opportunities. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 06KBNotification of cessation of securities - IXC. Grabbed my first ever parcel in IXC yesterdy at 80c. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. They'll still have 14-15M in cash plus ODD for TBI in Europe and soon, one from the FDA, with plans for a P2 TBI study. . . Last updated 10. So your thesis is right on a long time time frame. ASX - Day Trading. Andrew Forrest , or his entities have been involved with IXC since inception. Last edited by jellyroll: 27/02/23. Last updated 15. no point selling now. 7% #asx #ausbiz 23 Jun 2023 06:06:11Not been following IXC but it seems that this Orphan Drug Designation for TBI now have $0 value due to the other Phase III trial update and the company is. Click for more information. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited)At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. , page-3. 20 to $7. Market . 0% $ODM 35. Created with Sketch. IXC has alot of catching up to do. ASX - By Stock. Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Created with Sketch. 392 10/12/19 20:43 Post #: 41898691 Share @FullMoonFever Another chart request if you are up for it please thanks in advance IXC Valuation Report MST. In the LinkedIn About section for IXC, they list IIH, Acute Stroke and Traumatic Brain Injury. Top Smart Score Stocks. A new thread to put trading comments / reasoning / opinions in. IXC Valuation Report MST. . 26 area could be wrong and it could go for example to $3. Invex Granted Type C Meeting with FDA, page-3. HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Probably been disappointed like all of us Created with Sketch. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. ASX - By Stock. 0. 1950. But since the cash holding is double the market cap, there most likely more upside than down side. Invex issued US patent for Traumatic Brain Injury. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Created with Sketch. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. AX stock on Yahoo Finance. Created with Sketch. In 2005, IIH cost the American health care. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. ASX - Day Tradingis invex releasing 2. Issue of Tranche 1 Placement Shares and Appendix 2A. ASX - Day Trading. Created with Sketch. Share Ok news not the greatest but I dont think its as bad as people gonna re-act (mainly retailers) Primary endpoint remains unchanged Protocol changes focus on reordering secondary endpoints - replacing PMD with the more. About 90 percent of the U. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. ASX - By Stock. IXC Price at posting: 23. ASX - By Stock. ASX - By Stock. But there are two key factors that make me hope that the BoD pursues the Phase 2, but I worry that JP and co will push for the. Latest Posts. wonder if the GLP-1 agonist referred to in this media release. Plus, the opportunity to explore other conditions, including hydrocephalus and meningitis. Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. . pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - By Stock. . ASX - Day TradingI sold around half my shares yesterday at 25c. . Forums. , page-6. Below is the broker data for IXC November to. . pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 00% 21. ASX - By Stock. 2 Upvote. Trading HaltIXC Valuation Report MST. ASX - General. Posted without a title, my bad hahaI was going for something like Invex - How much is it worth, when Phase 2 results hit in March 2020?Got this from IXC by email today. IXC Price at posting: $1. 76 (-1. Notification of cessation of securities - IXC. INVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-9 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. Invex Therapeutics Lists on ASXNo worries mate :), page-15. The announcement was certainly a setback but we're not dead in. ASX - By Stock. ASX - By Stock. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. . ASX - Day Trading. . . 0¢ Sentiment: Buy Disclosure: HeldHotCopper has news, discussion, prices and market data on GENESIS MINERALS LIMITED. 1956773. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Notice of Investor Call and Presentation, page-3. Anyone had a look at this or put an application in for some stock in the IPO?, page-2. How many friends and family got out after the last announcementshould have been released at the same time, page-34. I find this very intriguing and positive that in last few weeks about 1. , page-3. 0 Great. Join the HotCopper ASX share market forum today for free. Created with Sketch. , page-4. Lucky for you all IXC still sits at only 60 cents. . Advertise on HotCopper. Forums. ASX - Day Trading. Latest Posts. Created with Sketch. is there any news release, or SP increasing due to only the market showing interest, page-2. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. IXC Price at posting:. 19 Per share (Personal Estimate) vs MST Research report of $3. Spot on - filled the 1. Market . Market . Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-3. Latest Posts. Some people like to gamble on stocks, others invest. Share A few weeks ago in the lead up to the Phase 2 results invex included this slide on their slide deck - 'average 42 million increase in market cap after positive Phase 2 results'. Invex to Present at Virtual ASX Small and Mid-Cap ConferenceHealth & BiotechMay 24, 2020|Tim BorehamSHAREFrom the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a. a shell trading below cash backing, ripe. Discover historical prices for IXC. Latest Posts. , page-2. Just unfortunate to hit the black swan so badly here, both the. Latest Posts. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportMarch 20 (Reuters) - Invex Therapeutics Ltd (IXC) : APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL RECEIVED FROM BUNDESINSTITUT FÜR. IXC (ASX) Ann: Trading Halt - HotCopper. Currency in USD 38. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Forums. Target our investor community with our suite of Hotcopper Advertising opportunities. ASX - Day TradingIf anyone told me a year ago, "there is a chance IXC cant progress the trial and the management all get sacked" I would agree that there was a chance, but nullified to a 1-2% black swan and worth the upside return profile. They have acted appropriately. IXC Price at posting. Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. Charts. Report to HotCopper and itll be the end of it, cheers. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. IXC Valuation Report MST. ASX - Day Trading0. June 15 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES WRITTEN RESPONSE FROM FDA ON TYPE C MEETING ON PHASE III CLINICAL TRIAL DESIGN FOR. Created with Sketch. 0¢ Sentiment: Buy Disclosure: Held. Currency in USD 38. 0 Great analysis. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-5. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious. Below is the broker data for IXC November to. Created with Sketch. Commodities. Therefore Id bet the same bet with the same info again. Strong buy side, sell side still very thin. I'm topping up. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. . Update - Notification regarding unquoted securities - IXC. It seems a massive hole within the industry of treatment *cough cough* IXC Also surprised by the amount of activity and people who have the disease. Andrew Forrest , or his entities have been involved with IXC since inception. . Charts. 0. Folks say we are pioneers of craft ice cream in Victoria. 91%) As of 03:35PM EST. *Close price adjusted for splits. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumIXC need to hold a conference call to discuss the announcement - they need to front up. Created with Sketch. , page-4. Created with Sketch. Mernova, a subsidiary of Melodiol Global Health (ASX:ME1), is on track to achieve its highest ever monthly sales, with revenues expected to reach A$891,944 in October 2023. Invex Therapeutics Ltd. International Markets. Join the HotCopper ASX share market forum today. Market . 20. If IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. Market . ASX - General. ASX - General. , page-3. Forums. ASX - By Stock. ASX - By Stock. 5% last year. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. Notice of Investor Call and Presentation, page-2. Forex. Company has options because they have cash. Update - Notification regarding unquoted securities - IXC. ASX - By Stock. Created with Sketch. Umbrella Society is a proud Living Wage Employer! Greater Victoria's official living wage has been adjusted to $25. ASX - By Stock. Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. 59). 1. 69KBThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. ASX - Day Trading. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. . ASX - Short Term Trading. Target our investor community with our suite of Hotcopper Advertising opportunities. Discover historical prices for IXC. . Forums. Created with Sketch. 3. 3¢. Forums. Forums. Market . IXC Valuation Report MST. . Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. The company can always acquire something new or do some capital returns. ASX - By Stock. Created with Sketch. 0¢ Sentiment: Buy Disclosure: Held. . Notification of cessation of securities - IXC. pause in tradingHere we go! AU and UK sites activated for immediate recruitment. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Created with Sketch. ASX - Short Term Trading. Latest Posts. . 40 in May 2020 and has only fallen over the subsequent 36 months. 63%. $45M MC $30M Cash and a $1. ASX - By Stock. DJPIN. 5 cents. you post every single trade that is a sell onto Hotcopper. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. 375,000. My. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. . Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. ASX - Day Trading. Plans & Pricing. ASX - Day TradingCreated with Sketch. , page-2. ASX - Day TradingWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. ASX - By Stock. Date of AGM and Closing Date for Director NominationsCD is on the money once again, page-195. Yet since market announcement of Phase 2 completion, this. 4KB OECCreated with Sketch. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. 4. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-2. ASX - By Stock. Australia's largest stock trading and investment forum Australia's #1 stock forumInvex Successfully Concludes Protocol Assistance with EMA, page-2. Australia's largest stock trading and investment forum Australia's #1 stock forumMay 18 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX THERAPEUTICS SEEKS TRADING HALT PENDING RELEASE ON RESULTS OF ITS PHASE II TRIAL & UNDERTAKING A. AX stock on. Forums. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. Last updated 10. 3¢. is 19. , page-2.